Omeros Stock Fundamentals
| 3O8 Stock | EUR 11.15 0.04 0.36% |
Omeros fundamentals help investors to digest information that contributes to Omeros' financial success or failures. It also enables traders to predict the movement of Omeros Stock. The fundamental analysis module provides a way to measure Omeros' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omeros stock.
Omeros |
Omeros Company Shares Owned By Insiders Analysis
Omeros' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Omeros Shares Owned By Insiders | 4.03 % |
Most of Omeros' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omeros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 4.028% of Omeros are shares owned by insiders. This is 73.47% lower than that of the Healthcare sector and 71.59% lower than that of the Biotechnology industry. The shares owned by insiders for all Germany stocks is 60.08% higher than that of the company.
Omeros Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Omeros's current stock value. Our valuation model uses many indicators to compare Omeros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omeros competition to find correlations between indicators driving Omeros's intrinsic value. More Info.Omeros is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Omeros' earnings, one of the primary drivers of an investment's value.Omeros Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omeros' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omeros could also be used in its relative valuation, which is a method of valuing Omeros by comparing valuation metrics of similar companies.Omeros is currently under evaluation in shares owned by insiders category among its peers.
Omeros Fundamentals
| Return On Asset | -0.36 | |||
| Operating Margin | 5.54 % | |||
| Current Valuation | 233.4 M | |||
| Shares Outstanding | 62.73 M | |||
| Shares Owned By Insiders | 4.03 % | |||
| Shares Owned By Institutions | 32.61 % | |||
| Price To Earning | (8.00) X | |||
| Price To Book | 8.23 X | |||
| Price To Sales | 4.82 X | |||
| Gross Profit | (71.4 M) | |||
| EBITDA | (170.49 M) | |||
| Net Income | 194.24 M | |||
| Cash And Equivalents | 47.22 M | |||
| Cash Per Share | 0.96 X | |||
| Total Debt | 313.46 M | |||
| Debt To Equity | 902.60 % | |||
| Current Ratio | 1.73 X | |||
| Book Value Per Share | (0.74) X | |||
| Cash Flow From Operations | (109.72 M) | |||
| Earnings Per Share | (2.63) X | |||
| Target Price | 34.63 | |||
| Number Of Employees | 213 | |||
| Beta | 1.18 | |||
| Market Capitalization | 209.78 M | |||
| Total Asset | 419.27 M | |||
| Net Asset | 419.27 M |
About Omeros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omeros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omeros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omeros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system , and immune-related diseases. The company was incorporated in 1994 and is based in Seattle, Washington. OMEROS CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 236 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Omeros Stock
When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Omeros Stock please use our How to Invest in Omeros guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.